Potassium Cyanate as an Inhibitor of the Sickling of Erythrocytes In Vitro
The recent use of urea as a treatment for the crisis phase of sickle-cell anemia has prompted us to investigate the possibility that cyanate, which is in equilibrium with urea in solution, might itself prevent the sickling of erythrocytes. We have found that in contrast to the high concentration of...
Guardat en:
| Publicat a: | Proc Natl Acad Sci U S A |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
National Academy of Sciences
1971
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC389147/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/5288366/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.68.6.1180 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|